BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Sickle Cell Disease

Gamida Cell Presents Positive Data From Phase 1/2 Study of NiCord® as a Curative Treatment for Sickle Cell Disease at ASH 2016

December 6, 2016 By Cade Hildreth (CEO) Leave a Comment

Gamida Cell - NiCord

Sickle cell disease patients treated with NiCord® showed rapid engraftment and were cured of disease symptoms.

Gamida CellJerusalem, Israel, Tuesday, December 6, 2016 — Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, today announced results from its Phase 1/2 study of NiCord® for Sickle Cell Disease (SCD). The data were presented during a poster session at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, December 3-5, 2016 in San Diego, CA. [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: cord blood, gamida cell, HSCT, NiCord, Sickle Cell Disease

Kirk, Manchin, Collins Introduce Bill to Speed Development of Regenerative Medicine

March 16, 2016 By Cade Hildreth (CEO) 1 Comment

Kirk, Manchin, Collins Introduce Bill to Speed Development of Regenerative Medicine

In major news released today, the Office of U.S. Senator for Illinois, Mark Kirk, announced the introduction of The REGROW Act, a bill designed to “reduce barriers to medical innovation and accelerate the development of new regenerative medicine treatments.”

The legislation could substantially support stem cell innovation, as it requires the “FDA to collaborate with stakeholders to develop standards that will lead to manufacturing processes and controls for safe regenerative medicine products.”

The ability of stakeholders to work collaboratively with the FDA has been a major hot topic lately, with a FDA Public Hearing to review four draft guidances controlling the regulation of stem cells recently postponed due to an unexpectedly large number of registrations (approximately 600). It is my opinion – and one that is shared by most advocacy groups – that the large turn-out for this FDA public hearing was a successful effort to communicate patient concerns to the FDA and a way to indicate that more input is needed in the regulatory process.

Most impressively, the REGROW Act is supported by leading groups within the regenerative medicine space, including: [Read more…]

Filed Under: Press Releases, Stem Cells Tagged With: Alzheimer's, Joe Manchin, Mark Kirk, Parkinson's, regenerative medicine, Sickle Cell Disease, stroke, Susan Collins, The REGROW Act

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.